Test Price
2,800 AEDโ Home Collection Available
NRAS Gene Noonan Syndrome Type 6 Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
Clinical-Grade Accuracy & Trust Commitments
- Clinical-Grade Accuracy: 99.9% Diagnostic Sensitivity achieved via our ISO 9001:2015 Certified Processing Facility (Cert: INT/EGQ/2509DA/3139), ensuring results you can act upon with confidence.
- Premium Logistics at Your Doorstep: Paid Hospital-Grade Home Collection using ISO Certified Cold-Chain transport for sample integrity. VIP Mobile Phlebotomy service available 8 AM โ 11 PM across all Emirates.
- Post-Test Clinical Guidance: Complimentary telephonic consultation with a DHA-licensed genetic expert to interpret your results and discuss next steps.
- Direct Insurance Billing: Verify coverage instantly via WhatsApp +971 54 548 8731 before booking. We handle paperwork for all UAE insurers.
Test Overview & Methodology
The NRAS Gene Noonan Syndrome Type 6 NGS Test comprehensively screens the entire coding region of the NRAS gene using Next-Generation Sequencing, detecting single-nucleotide variants, small insertions/deletions, and copy-number changes with a detection rate of >99.9%. This test provides molecular confirmation essential for managing Noonan syndrome type 6.
| Comparison Parameter | Our NRAS NGS Test | Standard Sanger Sequencing |
|---|---|---|
| Technology | NGS (Next-Generation Sequencing) | Capillary Electrophoresis |
| Gene Coverage | Full coding region + intron boundaries | Usually limited to hotspot exons |
| Analytical Sensitivity | >99.9% | ~95% (misses deep intronic variants) |
| Turnaround Time | 3โ4 Weeks | 4โ6 Weeks |
| Variant Interpretation | ACMG-graded, clinically curated | Often limited to known mutations |
| UAE Regulatory Alignment | DHA & Federal PDPL compliant | Varies by provider |
Physician Insight & Safety Protocols
โThe NRAS gene test provides molecular confirmation essential for managing Noonan syndrome type 6, but it must never replace a thorough physical examination and family history. I advise all families to approach genetic results as one piece of a larger clinical puzzle, integrating them with cardiology and developmental assessments. Please rememberโno test is a substitute for the judgment of a qualified paediatrician.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory Note
โ ๏ธ Clinical Context: Do not discontinue or modify any prescribed medication based solely on this test result without explicit consultation with your treating physician. Abrupt changes can pose serious health risks. This test is a diagnostic aid, not a standalone treatment guide.
Safety Exclusion & Red Flags
- Exclusion: This test is unsuitable for patients who have undergone allogeneic bone marrow transplantation (donor DNA may confound results).
- Exclusion: Prenatal samples require an amniocentesis confirmation; chorionic villus sampling alone is not accepted without additional maternal cell contamination testing.
- Emergency Red Flags: If the patient experiences new-onset severe bleeding, respiratory distress, or signs of heart failure (swelling, extreme fatigue), seek immediate emergency care or call 998. These may indicate underlying Noonan-related complications.
Patient FAQ & Clinical Guidance
1. What is the NRAS gene and its connection to Noonan syndrome type 6?
Direct Answer: The NRAS gene instructs the body to produce a protein that regulates cell growth; harmful mutations cause Noonan syndrome type 6, a multisystem disorder characterised by short stature, congenital heart defects, and distinctive facial features. Our test identifies these mutations from blood or DNA, enabling precise diagnosis and tailored medical management.
2. How reliable is the NGS technology for detecting NRAS mutations in the UAE?
Direct Answer: Our ISO-certified NGS platform delivers >99.9% analytical sensitivity and specificity for NRAS variants, validated against reference standards under a DHA-approved quality management system. Every report is reviewed by a board-certified clinical geneticist and complies with UAE genetic data regulations.
3. What is the turnaround time and price for the NRAS gene test in Dubai?
Direct Answer: Results are delivered in 3 to 4 weeks from sample collection at a cost of 2800 AED, fully inclusive of pre-test genetic counselling, home collection, and post-test clinical interpretation support. We also assist with direct insurance billing to minimise out-of-pocket expenses.
4. Can I receive the test without visiting a hospital?
Direct Answer: Yes, this test uses a standard peripheral blood sample. Our VIP Mobile Phlebotomy service is available daily from 8 AM to 11 PM across all Emirates, ensuring sample integrity through temperature-controlled cold-chain transport.
5. How are my genetic data protected under UAE law?
Direct Answer: Your data is processed and stored within UAE sovereign infrastructure, fully compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. A Data Protection Officer oversees all privacy measures.
UAE Regulatory & Data Privacy Adherence
Data Privacy & Legal Compliance: This service adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability. The laboratory is licensed by the Dubai Health Authority (DHA) under facility license number 1143 and operates under an ISO 9001:2015 Quality Management System (Cert: INT/EGQ/2509DA/3139). All genetic data is processed and stored within UAE sovereign infrastructure. For complaints or privacy inquiries, contact our Data Protection Officer at dpo@dnavation.ae.
Clinical & Logistical Metadata
| Test Name | NRAS Gene Noonan Syndrome Type 6 NGS Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3โ4 Weeks |
| Sample Type / Matrix | Peripheral whole blood (3โ5 mL EDTA) โ VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection Available Daily 8 AMโ11 PM |
| Methodology Used | Next-Generation Sequencing (NGS) โ Full coding region + intron boundaries |
| ICD-10-CM Code | Q87.19 (Other specified congenital malformation syndromes predominantly affecting face) |
| LOINC Code | 79509-3 (NRAS gene mutation analysis in blood or tissue by molecular genetics method) |
| DHA Facility License & Laboratory Address | License: 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE โ DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians